The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs

Ulrich H Weidle1, Alexandra Epp2, Fabian Birzele3

  • 1Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany ulrich.brinkmann@roche.com weidle49@t-online.de.

Insights

Micro-RNAs (miRs) significantly influence prostate cancer metastasis. This review details how specific miRs promote or inhibit cancer spread and explores their therapeutic potential for bone metastases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer mortality is largely driven by bone metastasis.
  • Micro-RNAs (miRs) are implicated in cancer progression and metastasis.
  • Understanding miR roles is crucial for developing targeted therapies.

Purpose of the Study:

  • To review the role of micro-RNAs (miRs) in prostate cancer metastasis.
  • To correlate preclinical in vivo data with clinical prognostic data for miRs.
  • To explore miR-based therapeutic strategies for prostate cancer bone metastases.

Main Methods:

  • Literature review focusing on miRs with preclinical metastasis data and clinical prognostic data.
  • Analysis of miR expression (up-regulation/down-regulation) in prostate cancer tissues versus normal tissues.
  • Examination of miR targets, including signaling pathways, epigenetic regulators, and cell cycle genes.

Main Results:

  • Specific miRs are up-regulated or down-regulated in prostate cancer, influencing metastasis.
  • Up-regulated miRs often target tumor suppressors and metastasis inhibitors.
  • Down-regulated miRs promote epithelial-mesenchymal transition and pro-metastatic signaling.

Conclusions:

  • Micro-RNAs play a critical role in prostate cancer metastasis, particularly to bone.
  • MiRs can target multiple pathways, including epigenetic and cell-cycle related genes.
  • Therapeutic strategies involving miR substitution or inhibition show promise for treating metastases.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.5K